Role of impurities profiling takes new significance within pharma industry
SCIEX, Beckman Coulter Life Sciences and Express Pharma, organised a seminar on 'Importance of impurities profiling and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Sun Pharma posts Q4 & FY17 results
In Q4FY17 the consolidated sales / income from operations was at Rs 6,825 crores
Glenmark receives ANDA approval for Olmesartan Medoxomil tabs
The tablets will be manufactured at its Goa facility
Glenmark Pharmaceuticals has been granted final approval by the US FDA for…
Digital A Plus hosts Asia Pacific multichannel marketing expert meeting
The event was attended by delegates from the industry who offered their insights on the theme ‘Reshaping the future of Pharma’
Cipla announces Q4 & FY17 results
Cipla reports Q4 net loss of Rs. 61.8 crores, whereas the revenue was up by 8 per cent
Havas Group acquires Sorento
The addition serves to establish Havas Health & You with a cornerstone health-and-wellness agency in the growing Indian market…
Growth hormone deficiency market to grow steadily : GlobalData
The global growth hormone deficiency (GHD) space, which covers the seven major markets is set to rise to $2.08 billion by 2026
GNH imports Olaratumab to India
It is a monoclonal antibody developed for the treatment of solid tumours soft tissue sarcomas
Clariant announced its financial results for the year ended March 31, 2017
Net Sales for the 12 months ended March 2017 grew by 7.9 per cent, the Board recommends a final dividend of Rs 25/- per share
Sun Pharma received US FDA acceptance of BLA for Tildrakizumab
Tildrakizumab is being evaluated for treatment of moderate-to-severe plaque psoriasis